Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 55,661 shares at $56.97 ($3.2M) on 2020-02-27, disclosed to the SEC on 2020-02-28.
Open-market sale of $3.2M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.70 | 13,619 | $799K | 24.7% |
| 2 | $58.70 | 13,619 | $799K | 24.7% |
| 3 | $59.91 | 2,365 | $142K | 4.4% |
| 4 | $59.91 | 2,530 | $152K | 4.7% |
| 5 | $56.97 | 9,837 | $560K | 17.3% |
| 6 | $56.97 | 9,837 |
| $560K |
| 17.3% |
| 7 | $58.42 | 3,854 | $225K | 7.0% |
| Total | $58.18 avg | 55,661 | $3.2M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |